Correlation Between Tryp Therapeutics and Biovaxys Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tryp Therapeutics and Biovaxys Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tryp Therapeutics and Biovaxys Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tryp Therapeutics and Biovaxys Technology Corp, you can compare the effects of market volatilities on Tryp Therapeutics and Biovaxys Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tryp Therapeutics with a short position of Biovaxys Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tryp Therapeutics and Biovaxys Technology.

Diversification Opportunities for Tryp Therapeutics and Biovaxys Technology

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Tryp and Biovaxys is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Tryp Therapeutics and Biovaxys Technology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovaxys Technology Corp and Tryp Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tryp Therapeutics are associated (or correlated) with Biovaxys Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovaxys Technology Corp has no effect on the direction of Tryp Therapeutics i.e., Tryp Therapeutics and Biovaxys Technology go up and down completely randomly.

Pair Corralation between Tryp Therapeutics and Biovaxys Technology

If you would invest  5.00  in Tryp Therapeutics on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Tryp Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Tryp Therapeutics  vs.  Biovaxys Technology Corp

 Performance 
       Timeline  
Tryp Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tryp Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tryp Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Biovaxys Technology Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Biovaxys Technology Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting basic indicators, Biovaxys Technology reported solid returns over the last few months and may actually be approaching a breakup point.

Tryp Therapeutics and Biovaxys Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tryp Therapeutics and Biovaxys Technology

The main advantage of trading using opposite Tryp Therapeutics and Biovaxys Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tryp Therapeutics position performs unexpectedly, Biovaxys Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovaxys Technology will offset losses from the drop in Biovaxys Technology's long position.
The idea behind Tryp Therapeutics and Biovaxys Technology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance